The SPCC794.15 Antibody (product code: CSB-PA891598XA01SXV) is a polyclonal antibody raised against the SPCC794.15 protein in S. pombe. It is distributed in two formats: 2ml and 0.1ml volumes, optimized for immunological assays .
| Attribute | Details |
|---|---|
| Target Protein | SPCC794.15 (uncharacterized protein in S. pombe) |
| Species Reactivity | Schizosaccharomyces pombe (strain 972 / ATCC 24843) |
| Immunogen | Recombinant protein corresponding to SPCC794.15 |
| Conjugate | Unconjugated (suitable for downstream labeling or detection systems) |
| Dilution | Recommended for Western blot (1:500–1:1000), immunoprecipitation (1:50) |
The antibody has been utilized in studies focusing on yeast cell biology, particularly in the context of cell wall dynamics and glycosylation. Key applications include:
Immunoprecipitation: Used to isolate SPCC794.15 protein complexes for downstream analysis .
Western Blotting: Detects SPCC794.15 in whole-cell lysates or subcellular fractions .
Cell Wall Studies: The target protein is implicated in cell wall remodeling processes, as inferred from its co-localization with β-1,3-glucan synthases in S. pombe .
A 2025 thesis investigating S. pombe cell wall proteins employed the SPCC794.15 Antibody to study protein glycosylation and septum formation . Key findings include:
Role in Glycosylation: SPCC794.15 interacts with GPI-anchored proteins, critical for cell wall integrity .
Septum Dynamics: The antibody revealed abnormal β-1,3-glucan deposits at the septum in mutant strains, suggesting a role in septum closure .
O-Mannosylation: SPCC794.15 undergoes hypo-mannosylation in oma4Δ mutants, enabling N-glycosylation at an unusual sequon .
The thesis highlights the antibody’s utility in advanced techniques:
SPCC794.15 is a hypothetical protein in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast . While its function remains largely uncharacterized, it is of interest to researchers studying fundamental aspects of cell biology, particularly those examining gene expression patterns in fission yeast.
The protein is often studied in the context of:
Cell cycle regulation in eukaryotic models
Gene expression patterns during various cellular states
Comparative genomics across yeast species
Protein-protein interaction networks
Research involving SPCC794.15 typically aims to elucidate its biological role through gene deletion studies, expression analysis, and protein interaction mapping in S. pombe .
The SPCC794.15 antibody can be employed in several standard detection methods commonly used in molecular and cellular biology:
Western blotting: For detecting the protein in cell lysates and determining its molecular weight
Immunoprecipitation (IP): For isolating SPCC794.15 and its binding partners
Immunohistochemistry (IHC): For localization studies in fixed yeast cells
Immunofluorescence (IF): For studying subcellular localization and co-localization with other proteins
ELISA: For quantitative detection of the protein
These applications depend on the specific properties of the antibody preparation, including binding affinity, specificity, and whether it recognizes native or denatured forms of the protein .
Proper validation of SPCC794.15 antibody specificity is crucial for reliable experimental results. Recommended validation steps include:
Negative controls: Test the antibody against samples from SPCC794.15 deletion mutants
Positive controls: Confirm reactivity with recombinant SPCC794.15 protein
Cross-reactivity assessment: Test against related proteins from other yeast species
Western blot analysis: Verify that the antibody detects a band of the expected molecular weight
Competitive blocking: Pre-incubation with purified antigen should abolish signal
Multiple detection methods: Confirm results using orthogonal techniques
For genetic validation, researchers can use the available S. pombe deletion strain collection, which includes a SPCC794.15 deletion mutant, to verify antibody specificity .
SPCC794.15 has been observed in studies examining periodic gene expression patterns in fission yeast . For cell cycle and gene expression analyses:
Synchronization experiments: Use the antibody to track SPCC794.15 protein levels in synchronized yeast cultures (e.g., cdc25 'block and release' or elutriation experiments)
Co-immunoprecipitation: Identify interaction partners that may provide functional insights by:
Crosslinking cells with formaldehyde
Lysing cells under conditions that preserve protein complexes
Immunoprecipitating with SPCC794.15 antibody
Analyzing co-precipitated proteins by mass spectrometry
ChIP-seq applications: If SPCC794.15 has DNA-binding properties, chromatin immunoprecipitation can identify genomic binding sites:
Crosslink protein-DNA complexes in vivo
Fragment chromatin
Immunoprecipitate with SPCC794.15 antibody
Sequence associated DNA fragments
Transcriptional regulation studies: Compare expression of SPCC794.15 with transcription factors known to be active during the cell cycle
For successful immunoprecipitation of SPCC794.15:
Buffer optimization:
Test both native (non-denaturing) and denaturing conditions
For membrane association studies, include appropriate detergents (e.g., 0.1-0.5% NP-40 or Triton X-100)
Include protease inhibitors to prevent degradation
Antibody amounts:
Titrate antibody concentration (typical range: 1-5 μg per reaction)
Pre-clear lysates to reduce non-specific binding
Consider using magnetic beads conjugated with Protein A/G for efficient capture
Crosslinking considerations:
For transient interactions, use crosslinking reagents like formaldehyde (1%) or DSP
For protein complex stabilization, optimize crosslinking time (typically 10-30 minutes)
Controls:
Include isotype control antibodies
Use lysates from SPCC794.15 deletion strains as negative controls
For tagged proteins, compare results with tag-specific antibodies
Interpretation of SPCC794.15 expression requires careful consideration of cellular context:
Growth conditions influence:
Data normalization strategies:
Use multiple reference genes for quantitative PCR
For protein quantification, normalize to total protein or established housekeeping proteins
Consider the effects of cell synchronization on reference gene expression
Comparative analysis framework:
| Condition | Expected Expression | Detection Method | Considerations |
|---|---|---|---|
| Log phase | Variable (baseline) | Western blot/qPCR | Standard extraction conditions |
| Stationary | May differ from log phase | Western blot/qPCR | More challenging extraction |
| Stress conditions | Potentially regulated | Western blot/qPCR | Verify with multiple antibodies |
| Cell cycle phases | Potentially periodic | Time-course Western blot | Synchronize cultures |
Integration with transcriptomic data:
Compare protein levels with available RNA-seq or microarray data
Assess correlation between mRNA and protein abundance
Consider post-transcriptional regulation mechanisms
S. pombe presents unique challenges for immunofluorescence due to its cell wall. For optimal results:
Cell wall digestion protocol:
Use enzymatic digestion with zymolyase or novozyme
Optimize digestion time to create cell wall porosity without compromising cellular structures
Consider using cell wall mutants for easier antibody penetration
Fixation methods:
Compare methanol fixation (-20°C, 6 minutes) with formaldehyde (3-4%, 30 minutes)
For preserving cytoskeletal structures, test glutaraldehyde addition (0.1-0.2%)
When examining membrane proteins, avoid methanol which can extract lipids
Antibody penetration strategies:
Include 0.1% Triton X-100 in blocking buffer to enhance permeabilization
Extend primary antibody incubation (overnight at 4°C)
Consider using antibody fragments (Fab) for better penetration
Co-localization studies:
Use known cellular markers (e.g., nucleus, ER, Golgi, vacuoles)
Employ super-resolution microscopy techniques for precise localization
Apply quantitative co-localization analysis methods
When facing specificity or sensitivity issues:
Non-specific binding remediation:
Increase blocking stringency (5% BSA or 5% milk in PBS-T)
Include 0.1-0.2% Tween-20 in wash buffers
Pre-adsorb antibody with lysate from SPCC794.15 deletion strain
Reduce primary antibody concentration or incubation time
Weak signal enhancement strategies:
Optimize protein extraction to preserve epitope integrity
Increase antibody concentration or incubation time
Use signal amplification systems (biotin-streptavidin, tyramide)
Try alternative epitope unmasking techniques for fixed samples
Systematic optimization approach:
| Parameter | Range to Test | Evaluation Method |
|---|---|---|
| Antibody dilution | 1:200 to 1:2000 | Signal-to-noise ratio |
| Blocking agent | BSA, milk, serum | Background reduction |
| Incubation time | 1h to overnight | Signal intensity |
| Detection system | Direct vs. amplified | Sensitivity comparison |
Epitope accessibility considerations:
If the protein forms complexes, adjust lysis conditions
For membrane-associated forms, include appropriate detergents
Consider native vs. denatured detection systems
SPCC794.15 research contributes to fission yeast biology in several ways:
Functional genomics completion:
Cell cycle regulation insights:
Evolutionary conservation analysis:
Comparing SPCC794.15 with homologs in other species can reveal evolutionarily conserved functions
Absence of homologs in certain lineages may indicate specialized functions in fission yeast
Systems biology integration:
Data on SPCC794.15 contributes to protein interaction networks and regulatory maps
Integration with transcriptomic, proteomic, and phenotypic data enhances systems-level understanding
Researchers should consider these factors when comparing antibody detection versus genetic tagging:
Epitope accessibility differences:
Antibodies recognize specific epitopes that may be masked in certain protein conformations
Tags (GFP, FLAG, etc.) may alter protein folding, localization, or function
Expression level impacts:
Endogenous promoter tagging maintains natural expression levels
Overexpression systems may create artifacts not seen with antibody detection of native protein
Detection sensitivity comparison:
Direct fluorescent tags often provide stronger signals for microscopy
Antibody-based detection can be amplified for enhanced sensitivity
Some low-abundance proteins may be detectable only after amplification
Functional validation strategies:
Complement genetic tagging with antibody detection where possible
Verify that tagged proteins retain wild-type functionality
Perform rescue experiments with tagged constructs in deletion backgrounds
Integration of SPCC794.15 antibody into multi-omics approaches:
Proteomics integration:
Use antibody for targeted proteomics to validate mass spectrometry findings
Apply for protein complex isolation prior to identification of interaction partners
Combine with SILAC or TMT labeling for quantitative analysis across conditions
Transcriptomics correlation:
Compare protein levels detected by the antibody with mRNA expression data
Investigate post-transcriptional regulation by analyzing protein/mRNA ratios
Identify conditions where protein and mRNA levels diverge
Chromatin biology studies:
If SPCC794.15 interacts with chromatin, use ChIP-seq to map binding sites
Correlate binding patterns with histone modifications or chromatin accessibility
Integrate with transcriptome data to identify potential regulatory relationships
Systematic phenotypic analysis:
Use antibody to track protein levels/localization in genetic interaction screens
Correlate protein abundance with phenotypic outcomes in genetic perturbation studies
Support high-content screening with automated image analysis
Several emerging technologies could advance SPCC794.15 antibody applications:
Advanced microscopy integration:
Super-resolution microscopy (STORM, PALM, SIM) for precise localization
Correlative light and electron microscopy (CLEM) to combine molecular specificity with ultrastructural context
Live-cell single-molecule tracking using antibody fragments
Proximity labeling approaches:
BioID or TurboID fusion proteins to identify proximal interacting partners
APEX2-based proximity labeling for ultrastructural localization
Split-BioID for detecting conditional or transient interactions
Spatial proteomics applications:
Antibody-based imaging mass cytometry for spatial protein mapping
Digital spatial profiling for quantitative spatial analysis
Multiplexed ion beam imaging for simultaneous detection of multiple proteins
Single-cell applications:
Antibody-based single-cell Western blotting
Mass cytometry (CyTOF) for high-dimensional protein profiling
Imaging flow cytometry for combined morphological and protein information
When faced with contradictory results:
Antibody validation comparison:
Assess specificity validation methods used in different studies
Compare antibody sources, clones, and epitopes recognized
Verify results with multiple antibodies targeting different epitopes
Experimental condition analysis:
Methodological reconciliation approach:
| Conflict Type | Investigation Strategy | Resolution Approach |
|---|---|---|
| Expression level | Compare extraction methods | Standardize protocols |
| Localization | Analyze fixation methods | Use multiple detection methods |
| Interaction partners | Review buffer conditions | Validate with reciprocal IP |
| Function | Examine genetic backgrounds | Perform epistasis analysis |
Integrated validation strategy:
Combine genetic approaches (deletion, tagging) with antibody-based methods
Use orthogonal techniques to verify key findings
Consider context-dependent protein behavior (cell cycle stage, stress conditions)
For studying post-translational modifications (PTMs):
Modification-specific detection strategies:
Generate or obtain modification-specific antibodies (e.g., phospho-specific)
Use general PTM enrichment methods (phosphopeptide enrichment, ubiquitin pulldown)
Apply mass spectrometry to identify modification sites
Experimental conditions that may affect PTMs:
Functional validation approaches:
Create non-modifiable mutants (e.g., S→A for phosphorylation)
Generate constitutively modified mimics (e.g., S→E for phosphorylation)
Apply chemical inhibitors of modification enzymes (kinases, phosphatases)
Technical considerations for preserving PTMs:
Include phosphatase inhibitors for phosphorylation studies
Add deubiquitinase inhibitors for ubiquitination analysis
Use appropriate fixation methods that preserve labile modifications